MedPath
TGA Approval

MOUNJARO tirzepatide 5 mg/0.5 mL solution for injection vial (407050)

407050

MOUNJARO tirzepatide 5 mg/0.5 mL solution for injection vial

Eli Lilly Australia Pty Ltd

July 10, 2023

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/7aba486418ac447f43670214772ad0c3.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/527c701de579f37b05e8d2e07895d704.pdf

Active Ingredients

tirzepatide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MOUNJARO tirzepatide 5 mg/0.5 mL solution for injection vial (407050) - TGA 批准文号 | MedPath